Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors

Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors

Abstract Background Cancer survival rates have been steadily improving in the adolescent and young adult (AYA) population, but survivors are at increased risk for cardiovascular disease (CVD). The cardiotoxic effects of anthracycline therapy have been well studied. However, the cardiovascular toxici...

Full description

Bibliographic Details
Main Authors: Jeannette R. Wong-Siegel, Robert J. Hayashi, Randi Foraker, Joshua D. Mitchell
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Cardio-Oncology
Subjects:
Cancer therapies
Cancer survivors
Cardiotoxicity
Online Access:https://doi.org/10.1186/s40959-023-00181-2

Similar Items

Similar Items